NeoGenomics Laboratories, Inc. Sustainability Profile
NeoGenomics Laboratories, Inc., a leading provider of cancer-focused genetic testing services, is headquartered in the United States. Founded in 2001, the company has established itself as a key player in the oncology diagnostics industry, with major operational regions across North America and Europe. Specialising in a comprehensive range of services, including molecular testing, pathology, and clinical trial support, NeoGenomics is renowned for its innovative approach to cancer diagnostics. The company’s commitment to high-quality, accurate testing has positioned it as a trusted partner for healthcare providers and researchers alike. With numerous accolades and a robust market presence, NeoGenomics continues to advance the field of oncology through cutting-edge technology and a dedication to improving patient outcomes.
DitchCarbon Score
How does NeoGenomics Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NeoGenomics Laboratories, Inc.'s score of 29 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
NeoGenomics Laboratories, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary of NeoGenomics, Inc., any potential emissions data or climate commitments would be inherited from the parent organisation. However, no specific information regarding emissions or climate initiatives has been provided from this source either. In the context of the industry, it is essential for companies like NeoGenomics to establish clear climate commitments and reduction targets to align with global sustainability goals. Without such data, it is challenging to assess their environmental impact or commitment to reducing carbon emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 536,000 |
| Scope 2 | 4,181,000 |
| Scope 3 | - |
How Carbon Intensive is NeoGenomics Laboratories, Inc.'s Industry?
How Carbon Intensive is NeoGenomics Laboratories, Inc.'s Location?
NeoGenomics Laboratories, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
NeoGenomics Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
